Education
About Us
Working with TipRanks
Follow Us
WTV - ETF AI Analysis
Top Page
WisdomTree US Value Fund of Benef Interest (WTV)
Rating:70Outperform
Price Target:
$101.00
Positive Factors
Low Expense Ratio
The ETF charges a very low expense ratio, making it cost-effective for investors.
Broad Sector Diversification
The fund is spread across multiple sectors, reducing the risk of overexposure to any single industry.
Steady Performance
The ETF has shown consistent positive returns over the year-to-date, three-month, and one-month periods.
Negative Factors
Over-Concentration in U.S. Market
The ETF is heavily focused on U.S. companies, offering minimal exposure to international markets.
Mixed Top Holdings Performance
Some of the largest positions, like UnitedHealth and HP, have underperformed year-to-date, which could drag on overall returns.
Limited Exposure to Growth Sectors
The fund has relatively low allocation to high-growth sectors like Technology and Communication Services.
WTV vs. SPDR S&P 500 ETF (SPY)
AUM1.88B
RegionNorth America
Expense Ratio0.12%
Beta0.90
IssuerWisdomTree
Inception DateFeb 23, 2007
Dividend Yield1.48%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume112,177
30 Day Avg. Volume108,956
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
103.46Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering136
WTV Summary
The WisdomTree US Value Fund (WTV) is an ETF that focuses on U.S. companies with strong financial health that are considered undervalued. It includes a mix of industries like financials, healthcare, and consumer goods, with top holdings such as UnitedHealth and Johnson & Johnson. This fund is designed for investors who want to invest in companies with solid fundamentals and potential for long-term growth while staying diversified across the U.S. market. However, new investors should know that the fund’s performance can be affected by overall market fluctuations and the specific risks of value stocks.
How much will it cost me?The WisdomTree US Value Fund (WTV) has an expense ratio of 0.12%, meaning you’ll pay $1.20 per year for every $1,000 invested. This is lower than average because it is a passively managed ETF, which typically has lower costs compared to actively managed funds.
What would affect this ETF?The WisdomTree US Value Fund (WTV) could benefit from a strong U.S. economy, particularly if sectors like financials, consumer cyclical, and health care continue to perform well, as these are key areas of exposure for the ETF. However, rising interest rates or economic slowdowns could negatively impact value stocks, especially in sectors like consumer cyclical and financials, which are sensitive to such changes. Regulatory shifts or unexpected challenges in top holdings like UnitedHealth, Johnson & Johnson, and Meta Platforms could also influence the fund's performance.
WTV Top 10 Holdings
The WisdomTree US Value Fund (WTV) leans heavily into value stocks across diverse sectors, with notable contributions from healthcare and consumer cyclical names. UnitedHealth and Johnson & Johnson are steady performers, bolstered by strong financials and growth prospects, while General Motors has been rising on solid revenue growth and market share gains despite challenges in EV profitability. Meta Platforms, however, has been lagging recently, with regulatory hurdles and high expenses weighing on its momentum. With its U.S.-focused portfolio, WTV offers a balanced approach to value investing, though some holdings face mixed signals.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| General Motors | 2.02% | $38.02M | $64.45B | 35.58% | 75 Outperform | |
| Johnson & Johnson | 1.73% | $32.50M | $455.04B | 17.95% | 78 Outperform | |
| UnitedHealth | 1.66% | $31.32M | $309.40B | -39.82% | 76 Outperform | |
| Roivant Sciences | 1.63% | $30.66M | $13.65B | 71.15% | 58 Neutral | |
| Fox | 1.60% | $30.03M | $27.23B | 54.37% | 77 Outperform | |
| HP | 1.50% | $28.18M | $25.86B | -23.73% | 63 Neutral | |
| Bank of New York Mellon | 1.49% | $27.99M | $75.26B | 43.31% | 79 Outperform | |
| Flex | 1.49% | $27.94M | $23.47B | 76.21% | 74 Outperform | |
| Citigroup | 1.46% | $27.55M | $186.35B | 58.89% | 67 Neutral | |
| Altria Group | 1.46% | $27.40M | $94.64B | 4.66% | 66 Neutral |
WTV Technical Analysis
Neutral
―
Price Trends
90.73
Negative
88.67
Positive
85.37
Positive
Market Momentum
0.18
Positive
46.64
Neutral
23.16
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For WTV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 90.87, equal to the 50-day MA of 90.73, and equal to the 200-day MA of 85.37, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 46.64 is Neutral, neither overbought nor oversold. The STOCH value of 23.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for WTV.
WTV Peer Comparison
Comparison Results
Performance Comparison
WTV
WisdomTree US Value Fund of Benef Interest
90.40
11.37
14.39%
DFAU
Dimensional US Core Equity Market ETF
―
―
―
CGUS
Capital Group Core Equity ETF
―
―
―
QLTY
GMO U.S. Quality ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
RDVI
FT Cboe Vest Rising Dividend Achievers Target Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents